Assembly Biosciences to Present at the J.P. Morgan Healthcare Conference
Jan 04, 2018 12:05 pm UTC| Business
INDIANAPOLIS, Jan. 04, 2018 -- Assembly Biosciences, Inc. (NASDAQ:ASMB), a clinical-stage biotechnology company advancing a new class of oral therapeutics for the treatment of hepatitis B virus (HBV) infection and novel...
Shire to present at the 36th Annual J.P. Morgan Healthcare Conference
Jan 04, 2018 12:01 pm UTC| Business
Shire to present at the 36th Annual J.P. Morgan Healthcare Conference Cambridge, MA - January 4, 2018 - Shire plc (LSE: SHP, NASDAQ: SHPG) announces that Flemming Ornskov, M.D., M.P.H., Chief Executive Officer, will...
Jan 04, 2018 12:01 pm UTC| Business
Shire Receives FDA Breakthrough Therapy Designation for Maribavir, an Investigational Treatment for Cytomegalovirus (CMV) Infection in Transplant Patients Cambridge, Mass. - January 4, 2018...
Vectura Group plc: 2017 Pre-close Trading Update and Refocussed Investment Strategy
Jan 04, 2018 12:01 pm UTC| Business
This announcement contains inside information Vectura Group plc 2017 Pre-close Trading Update and Refocussed Investment Strategy Chippenham, UK - 4 January 2018: Vectura Group plc (LSE: VEC) ("Vectura" or...
Jan 04, 2018 12:01 pm UTC| Business
PRESS RELEASE Immunocore Strengthens its Board with Appointments of Laura Wade-Gery and Kristine Peterson as Non-Executive Directors (Oxford, UK and Conshohocken, US, 4 January 2018) Immunocore Limited, the...
Inivata to present at the Biotech ShowcaseTM in San Francisco
Jan 04, 2018 12:01 pm UTC| Business
Inivata to present at the Biotech ShowcaseTM in San Francisco Company will also participate in "Generation Genome and Industrial Strategy: Leveraging UK Leadership in Genomics" Panel Research Triangle Park, NC...
Merus Provides Clinical Updates for MCLA-117 and MCLA-158 Programs
Jan 04, 2018 12:01 pm UTC| Business
- IND submitted to U.S. FDA for MCLA-117 in AML - - First CTA approval for MCLA-158 received in European country - UTRECHT, The Netherlands, Jan. 04, 2018 -- Merus N.V. (Nasdaq:MRUS), a clinical-stage...
Tim Cook Cashes Out $50M in Apple Stock, Fuels Market Buzz